ANCA-Associated Intrahepatic Duct Injury Associated with Levamisole-Adulterated Cocaine.

Case Reports in Hepatology Pub Date : 2020-12-22 eCollection Date: 2020-01-01 DOI:10.1155/2020/8867183
Joshua K Salabei, Sara Khan, Afzal Khan, Zekarias T Asnake, Troy J Fishman, Jonathan D Stromas, Zeeshan H Ismail, John R Leibach
{"title":"ANCA-Associated Intrahepatic Duct Injury Associated with Levamisole-Adulterated Cocaine.","authors":"Joshua K Salabei,&nbsp;Sara Khan,&nbsp;Afzal Khan,&nbsp;Zekarias T Asnake,&nbsp;Troy J Fishman,&nbsp;Jonathan D Stromas,&nbsp;Zeeshan H Ismail,&nbsp;John R Leibach","doi":"10.1155/2020/8867183","DOIUrl":null,"url":null,"abstract":"<p><p>Damage to the liver or kidney can occur through direct toxic effects; however, damage can also be drug-induced immune-mediated. Levamisole-adulterated cocaine (LAC) is known to cause antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis and glomerulonephritis leading to acute kidney injury and end-stage renal disease. It remains unclear whether LAC is associated with hepatic duct damage. Here, we report a case with biopsy-proven evidence of intrahepatic duct damage months after being diagnosed with ANCA-associated crescentic and sclerosing glomerulonephritis caused by LAC use. This case represents the first report of LAC-induced ANCA-associated hepatic duct cholestasis in the setting of previous LAC-induced ANCA-positive glomerulonephritis.</p>","PeriodicalId":30295,"journal":{"name":"Case Reports in Hepatology","volume":"2020 ","pages":"8867183"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773451/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8867183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Damage to the liver or kidney can occur through direct toxic effects; however, damage can also be drug-induced immune-mediated. Levamisole-adulterated cocaine (LAC) is known to cause antineutrophil cytoplasmic antibody- (ANCA-) associated vasculitis and glomerulonephritis leading to acute kidney injury and end-stage renal disease. It remains unclear whether LAC is associated with hepatic duct damage. Here, we report a case with biopsy-proven evidence of intrahepatic duct damage months after being diagnosed with ANCA-associated crescentic and sclerosing glomerulonephritis caused by LAC use. This case represents the first report of LAC-induced ANCA-associated hepatic duct cholestasis in the setting of previous LAC-induced ANCA-positive glomerulonephritis.

Abstract Image

左旋咪唑掺假可卡因与anca相关的肝内管损伤。
对肝脏或肾脏的损害可通过直接毒性作用发生;然而,损伤也可以是药物诱导的免疫介导的。已知左旋咪唑掺假可卡因(LAC)可引起抗中性粒细胞细胞质抗体(ANCA)相关的血管炎和肾小球肾炎,导致急性肾损伤和终末期肾病。目前尚不清楚LAC是否与肝管损伤有关。在这里,我们报告了一例活检证实肝内管损伤的病例,在被诊断为anca相关的月牙状和硬化性肾小球肾炎几个月后,由于LAC的使用。本病例是首次报道lac诱导的anca相关性肝管胆汁淤积在既往lac诱导的anca阳性肾小球肾炎中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
12
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信